Rubric Capital Management LP 13D and 13G filings for TherapeuticsMD, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-17 09:28 am Purchase | 2023-11-15 | 13D | TherapeuticsMD, Inc. TXMD | Rubric Capital Management LP | 2,946,908 25.730% | 877,192 (+42.38%) | Filing |
| 2023-06-30 08:29 am Purchase | 2023-06-28 | 13D | TherapeuticsMD, Inc. TXMD | Rubric Capital Management LP | 2,069,716 19.570% | 347,763 (+20.20%) | Filing |
| 2022-08-30 09:09 am Unchanged | 2022-08-23 | 13D | TherapeuticsMD, Inc. TXMD | Rubric Capital Management LP | 1,721,953 18.270% | 0 (Unchanged) | Filing |
| 2022-08-08 4:42 pm Purchase | 2022-08-04 | 13D | TherapeuticsMD, Inc. TXMD | Rubric Capital Management LP | 1,721,953 18.270% | 1,721,953 (New Position) | Filing |